The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2016

Filed:

Dec. 15, 2011
Applicants:

Regina Hourigan, Metuchen, NJ (US);

Jeffrey Mastrull, Flemington, NJ (US);

Jairajh Mattai, Piscataway, NJ (US);

James Masters, Ringoes, NJ (US);

Inventors:

Regina Hourigan, Metuchen, NJ (US);

Jeffrey Mastrull, Flemington, NJ (US);

Jairajh Mattai, Piscataway, NJ (US);

James Masters, Ringoes, NJ (US);

Assignee:

Cologne-Palmolive Company, New York, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61Q 11/00 (2006.01); A61Q 19/00 (2006.01); A61K 8/97 (2006.01); A61K 36/575 (2006.01); A01N 31/08 (2006.01); A61K 8/34 (2006.01); A61K 8/49 (2006.01); A61Q 19/10 (2006.01); A01N 25/02 (2006.01); A61Q 11/02 (2006.01); A61K 8/86 (2006.01);
U.S. Cl.
CPC ...
A01N 31/08 (2013.01); A01N 25/02 (2013.01); A61K 8/347 (2013.01); A61K 8/4973 (2013.01); A61K 8/4993 (2013.01); A61K 8/86 (2013.01); A61Q 11/00 (2013.01); A61Q 11/02 (2013.01); A61Q 19/10 (2013.01); A61K 2800/49 (2013.01);
Abstract

A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol and a sorbitan ester. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators. If isopropyl is selected, then the sorbitan ester is at least one of polyoxyethylene 20 sorbitan monooleate, and a proviso that if isobutyl magnolol is selected, then the sorbitan ester is poloxyethylene 20 sorbitan monooleate.


Find Patent Forward Citations

Loading…